L’Health Technology Assessment come strumento value-based per la valutazione delle tecnologie sanitarie. Reassessment del vaccino antinfluenzale quadrivalente da coltura cellulare: Flucelvax Tetra(®) 2.0

Detalles Bibliográficos
Autores principales: CALABRÒ, GIOVANNA ELISA, BOCCALINI, SARA, BECHINI, ANGELA, PANATTO, DONATELLA, DOMNICH, ALEXANDER, LAI, PIERO LUIGI, AMICIZIA, DANIELA, RIZZO, CATERINA, PUGLIESE, ANDREA, DI PIETRO, MARIA LUISA, ZANELLA, BEATRICE, PARENTE, FLAVIO, TROMBETTA, CARLO SIMONE, SARACENO, GIOVANNI, SOTTILE, SARA, ABREHA, FASIKA MOLLA, GIACCHETTA, IRENE, PROPERZI, SARA, SANTOLINI, GIULIA, D’AMBROSIO, FLORIANA, MAIDA, ADA, SCARDIGNO, ANNA, LA GATTA, EMANUELE, PETRELLA, LUIGI, BONANNI, PAOLO, DE WAURE, CHIARA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2023
Materias:
Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079375/
https://www.ncbi.nlm.nih.gov/pubmed/37034835
http://dx.doi.org/10.15167/2421-4248/jpmh2022.63.4s1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079375/
https://www.ncbi.nlm.nih.gov/pubmed/37034835
http://dx.doi.org/10.15167/2421-4248/jpmh2022.63.4s1

Ejemplares similares